DÄ internationalArchive38/2006Functional Neuroimaging in Psychiatry – Evaluation of Psychotherapy and Development of New Treatments

Review article

Functional Neuroimaging in Psychiatry – Evaluation of Psychotherapy and Development of New Treatments

Dtsch Arztebl 2006; 103(38): A-2472

Linden, D E J

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Dilger S, Straube T, Mentzel HJ et al.: Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study. Neurosci Lett 2003; 348: 29–32. MEDLINE
2. Baxter LR Jr, Schwartz JM, Bergman KS et al.: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681–9. MEDLINE
3. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME: Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 109–13. MEDLINE
4. Nakatani E, Nakgawa A, Ohara Y et al.: Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res 2003; 124: 113–20. MEDLINE
5. Nakao T, Nakagawa A, Yoshiura T et al.. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry 2005; 57: 901–10. MEDLINE
6. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51: 62–70. MEDLINE
7. Paquette V, Levesque J, Mensour B et al.: „Change the mind and you change the brain“: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003; 18: 401–9. MEDLINE
8. Straube T, Glauer M, Dilger S, Mentzel HJ, Miltner WHR: Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage 2006; 29: 125–135. MEDLINE
9. Furmark T, Tillfors M, Marteinsdottir I et al.: Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 2002; 59: 425–33. MEDLINE
10. Mayberg HS, Liotti M, Brannan SK et al: Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675–82. MEDLINE
11. Schneider F, Gur RE, Harper Mozley L et al.: Mood effects on limbic blood flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Research: Neuroimaging 1995; 61: 265–83. MEDLINE
12. Navarro V, Gasto C, Lomena F, Mateos JJ, Marcos T, Portella MJ: Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study. Neuroimage 2002; 16: 781–7. MEDLINE
13. Mayberg HS, Silva JA, Brannan SK et al.: The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159: 728–37. MEDLINE
14. Goldapple K, Segal Z, Garson C et al.: Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004; 61: 34–41. MEDLINE
15. Brody AL, Saxena S, Stoessel P et al.: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 58: 631–40. MEDLINE
16. Mayberg HS, Lozano AM, Voon V et al.: Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651–60. MEDLINE
17. Wilke E, Hautzinger M: Psychotherapie bei psychosomatischen Störungen. In: Reimer C, Eckert J, Hautzinger M, Wilke E: Psychotherapie, 2. Auflage. Berlin: Springer 2000; 436.
18. Birbaumer N, Ghanayim N, Hinterberger T et al.: A spelling device for the paralysed. Nature 1999; 398: 297–8. MEDLINE
19. Weiskopf N, Veit R, Erb M et al.: Physiological self-regulation of regional brain activity using real-time functional magnetic resonance imaging (fMRI): methodology and exemplary data. Neuroimage 2003; 19: 577–86. MEDLINE
20. deCharms RC, Maeda F, Glover GH et al.: Control over brain activation and pain learned by real-time functional MRI. Proc Nat Acad SciUSA 2005; 102: 18626–31. MEDLINE
21. Grawe K: Neuropsychotherapie. Göttingen: Hogrefe, 2004.
22. Roffmann JL, Marci CD, Glick DM, Dougherty DD, Rauch SL: Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med 2005; 35: 1385–98. MEDLINE
23. Brody AL, Saxena S, Schwartz JM et al.: FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Research Neuroimaging 1998; 84: 1–6. MEDLINE
24. Kandel ER: Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited. American Journal of Psychiatry 1999; 156: 505–24. MEDLINE
25. Martin SD, Martin E, Rai SS, Richardson MA, Royall R: Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001; 58: 641–8. MEDLINE
e1. Linden DEJ, Dierks T: Funktionelle Bildgebung akustischer Halluzinationen bei der Schizophrenie. Nervenheilkunde 2002; 21: 331–5.
e2. Kircher T, Schneider F, Sauer H, Buchkremer G: Funktionelle Bildgebung am Beispiel der Schizophrenie. Dtsch Arztebl 2004; 101: A–1975. VOLLTEXT
e3. Hariri AR, Weinberger DR: Imaging Genomics. British Medical Bulletin 2003;65: 259–70. MEDLINE
e4. Frodl T, Meisenzahl EM, Möller HJ: Bedeutung der bildgebenden Verfahren in der Beurteilung der Elektrokonvulsivtherapie. Nervenarzt 2004; 75: 227–33. MEDLINE
e5. Zobel A, Joe A, Freymann N, et al.: Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach. Psychiatry Res 2005; 139: 165–79. MEDLINE